Home/Filings/4/0001333277-19-000028
4//SEC Filing

Boudes Pol F 4

Accession 0001333277-19-000028

CIK 0001042074other

Filed

Jan 30, 7:00 PM ET

Accepted

Jan 31, 5:28 PM ET

Size

5.4 KB

Accession

0001333277-19-000028

Insider Transaction Report

Form 4
Period: 2019-01-29
Boudes Pol F
Chief Medical Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2019-01-29+138,312138,312 total
    Exercise: $8.43Exp: 2029-01-28Common Stock (138,312 underlying)
Footnotes (1)
  • [F1]The option vests as to 1/4 of the underlying shares on January 1, 2020, and vests as to 1/48 of the underlying shares monthly thereafter.

Issuer

CymaBay Therapeutics, Inc.

CIK 0001042074

Entity typeother

Related Parties

1
  • filerCIK 0001454771

Filing Metadata

Form type
4
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 5:28 PM ET
Size
5.4 KB